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ABSTRACT From a library of mouse sperm DNA, we have
isolated two overlapping clones which contain the Cc, gene. One
of these clones also contains the C,6 gene. The C gene is separated
from the C membrane exons by approximately 2 kilobases (kb)
of DNA. Ae Cc, gene was identified by (a) hybridization to
poly(A) RNA prepared from the IgD-producing rat plasma cell
tumor IR731, and (b) homology of a translated nucleotide se-
quence to the amino acid sequence of the human 8 chain. The C
gene spans 8 kb of DNA in the germ line. Plasmid subclones of
the Cc, gene were used as probes in Southern and RNA blot ex-
periments. RNA blot analysis of cytoplasmic poly(A)+RNA from
1R731 and a piA+8 B-cell hybridoma revealed 1.6- and 2.7-kb 8
mRNA species with different 3' ends, which presumably encode
the secreted and membrane-bound forms, respectively, of the 8
chain. Southern blot analysis of DNA from two ,u+8+ lymphomas
revealed that the C5g gene is in the germ-line configuration in each
case. Restriction map analysis of C and Cc, genomic clones iso-lated from a library of normal IA+8B-cell DNA also gave no evi-dence for DNA rearrangement in the region between the C, and
Cog genes. Taken together, these data suggest that IgD expression
in pI+B+ B cells does not involve a VH-to-Cs DNA switch rear-
rangement. We propose that simultaneous expression of CA and
Cc with a single V gene is mediated by two alternative routes of
RNA processing o? a primary nuclear transcript which contains
the VH, C , and Cc, genes. In contrast, analogous experiments with
myeloma TR731 DNA revealed that the C,, gene has been deleted
from the myeloma DNA and that the Cog gene has undergone DNA
rearrangement, presumably including a switch recombination of
the VH gene from the C to the Cc, gene. These results indicate
that two alternative meclanisms may be used in the expression of
IgD molecules-RNA splicing in B cells and DNA rearrangement
in plasma cells.
An immunoglobulin heavy chain is composed of a variable (VH)
region and one of five classes of constant (CH) region: CG (gM),
C,; (IgD), Cy (IgG), C. (IgA), and C. (IgE). In mice, the five CH
classes are encoded by eight distinct genes: CA, Cs, Cyr1 C*2,'
C,2b, C , C., and C.. Early in its development, a lymphocyte(B cell) bears only IgM on its surface; later, IgD molecules are
often expressed together with IgM molecules (for review, see
ref. 1). Upon interaction with antigen, a B cell proliferates and
differentiates, ultimately becoming a plasma cell. The class of
immunoglobulin produced by its progeny may change, from
IgM (and IgD) to IgG, IgA, or IgE.
The molecular mechanisms by which these genes are ex-
pressed during B-cell development have been partially char-
acterized. The VH gene is joined to the C. gene by assembly
of three gene segments: V, D, and J (2, 3). Presumably, upon
recognition of antigen, the VH gene, along with some C 5'-
flanking sequence, is joined to another C region in a phenom-
enon called the heavy-chain switch (4-6). Honjo and coworkers
(7, 8) have suggested that the intervening DNA, containing the
C, gene and perhaps other CH genes, is deleted.
Both IgM and IgD molecules are present on the surface of
the B cell. Experiments utilizing allotypic markers have shown
that their expression conforms to the rule of allelic exclusion:
both heavy chains on the surface of an individual cell are en-
coded by the same chromosome (9). Moreover, considerable
evidence suggests that these two cell-surface molecules bear
identical VH regions (10-13). These data are difficult to rec-
oncile with the CH gene deletion model because they imply that
a VH gene can be expressed with the Cog gene without concom-
itant deletion of the C, gene. A number of mechanisms have
been suggested to account for these observations, including the
"copy-insertion" mechanism (14) in which a copy of the VH gene
is joined to the C., gene while the original remains joined to the
C,, gene, and differential RNA processing of a single transcript
containing VH, C,,, and C5 genes (15).
This paper reports experiments carried out to test these hy-
potheses. The results support RNA splicing as the mechanism
by which the C,, and C, genes are expressed simultaneously in
B cells and also suggest that VH-to-CS DNA switch recombi-
nation may occur in plasma cells that express only IgD.
MATERIALS AND METHODS
Rat IgD Myeloma. The rat myeloma IR731 (16), a plasma-
cytoma, was passaged subcutaneously in Lou/M/Wsl N rats
(NIH). Total cell poly(A)+RNA was prepared from IR731 by a
method similar to that of Chirgwin et aL (17), followed by
oligo(dT)-cellulose chromatography. This RNA was hydrolyzed
with base to an estimated average size of -=500 nucleotides and
labeled with 32P by using [y-32P]ATP and polynucleotide kinase
for use as a probe. Cytoplasmic poly(A)+RNA for RNA blots was
prepared from IR731 as described (18).
BALB/c ,u'Bi Lymphomas. These lymphomas, the gen-
erous gifts of R. Asofsky and K. Jin Kim, were passaged sub-
cutaneously in BALB/c mice (19). The presence of cell-surface
IgM and IgD molecules was verified by immunofluorescence
using anti-IgM (Cappel) and monoclonal anti-IgD (Becton Dick-
inson) reagents. GCL-2.1 cells were from W. Raschke. DNA
from these and other tissues was prepared by the method of Blin
and Stafford (20).
Germ-Line Cc, Clones. The germ-line clone ChSptt7 has
been described (4, 21). The clone ChSp37 was isolated from the
same library of mouse sperm DNA as ChSpu7. The positions
of C, sequences in these clones were determined by hybrid-
ization of [5'-32P]poly(A)+RNA from IR731 to blots of restric-
tion digests of these clones. Subclones of the hybridizing re-
Abbreviations: VI,, heavy chain variable; C15, heavy chain constant; kb,
kilobase(s).
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gions were generated by ligation of restriction fragments into
the corresponding site or sites of pBR322 and were used as
probes in Southern (22) and RNA blot experiments. The cDNA
clone p104E~u12 (21) was used as a probe for C. sequences. The
JH probe, containing the JH gene cluster and 3'-flanking se-
quence, was prepared by M. Steinmetz.
BALB/c #u+6 Normal B-Cell DNA Library. IgM-positive
cells were isolated from BALB/c spleens by using a fluores-
cence-activated cell sorter. Ninety-three to 97% of the purified
cell population stained positively for surface IgM, and 99% was
positive for surface IgD. A library of 12 x 106 recombinant
phage was constructed by ligation of EcoRI partial digests of
A'S' spleen cell DNA to phage vector Charon 4A (23), followed
by in vitro packaging (24).
All manipulations of microorganisms containing recombinant
DNA were carried out under P2/EK2 or P2/EK1 conditions
prior to January 1980, after which P1/EK2 and P1/EK1 con-
ditions were used.
DNA sequence analysis was as described (25).
RESULTS AND DISCUSSION
Characterization of Genomic Clones. [5'-32P]Poly(A)+RNA
prepared from IR731 was used to screen a number of genomic
clones known to contain mouse immunoglobulin CH region
genes or their flanking sequences. Two BALB/c sperm DNA
clones, ChSpju7 and ChSp37, hybridized to this probe. These
clones were subjected to restriction map analysis (Fig. 1). The
[5'-32P]poly(A)+RNA probe hybridized to three discrete regions
of the cloned DNA.
Identification of the Cc, Gene. Restriction fragments hy-
bridizing to IR731 poly(A)+RNA were subcloned into the plas-
mid vector pBR322 (Fig. 1). A DNA sequence determined near
the 3' end of the p624 clone (Fig. 2, part B) appeared to encode
the first third of an immunoglobulin domain, with a cysteine
residue and several conserved amino acids in the appropriate
positions. This amino acid sequence is translated from the only
open reading frame and is associated with a possible down-
stream splicing site. This sequence displays striking homology
to the protein sequence of the C&3 domain of human IgD (26):
18 of 33 residues, including a stretch of 10 surrounding the
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FIG. 2. Partial restriction map of p824 and strategy for determi-
nation of nucleotide sequence.
cysteine residue are identical, and an additional 10 are either
conservative substitutions or can be attributed to a single-base
difference in the genetic code. Thus, this sequence codes for
the C,3 domain of mouse IgD.
Additional sequence determinations in the 5' region of p824
(Fig. 2, part A) revealed no additional immunoglobulin domain
coding sequences, and the unsequenced portion (coordinates
470-700) is too small to encode a complete immunoglobulin
domain. Additional domain and hinge regions presumably lie
in p62 because no hybridization of IR731 RNA was observed
5' to the 10.2-kb EcoRI fragment (Fig. 1). We conclude that in
the germ-line the C; gene is separated from the C,, M exons by
>2kb.
C, Gene Encodes Two mRNAs with Alternative 3' Ends.
The germ-line DNA subeloned in p62 contains the CS3 domain
of the 6 gene and, as argued above, probably additional C8 do-
mains as well. Labeled total cellular poly(A)+RNA from IR731
also hybridized with sequences 3-7 kb to the C83 encoding se-
quence (Fig. 1). These regions were subcloned as p632 and p68.
Both p632 and p68 contain only single-copy sequences and do
not cross hybridize with each other or with p62. That this DNA
also contains 6 gene sequences was demonstrated by RNA blots
with IR731 mRNA and nick-translated p632 and p68 as probes.
Hybridization of C, probes (p62) to IR731 poly(A)+mRNA re-
vealed a major 6 mRNA species of 1.6 kb and a minor species
of 2.7 kb (Fig. 3). In addition, the 1.6-kb species hybridized
with p832, and the 2.7-kb mRNA hybridized with p68. These
results suggest that p632 and p68 contain separate, noncontig-
uous gene segments which represent alternative 3' ends for the
1.6- and 2.7-kb mRNAs. At present we do not know whether
each gene sequence is composed of one or more exons. None-
theless, these results indicate that C8 gene sequences that are
contiguous in 6 mRNA occupy about 8 kb of germ-line DNA.
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FIG. 1. Restriction map of ChSpIu7 and ChSp37. Restriction frag-
ments of a particular digest that hybridize to [5'-32P]poly(A)+RNA
from ER731 are indicated by heavy lines. Bgi I and Xho I digests were
not tested for hybridization to ER731 RNA. Plasmid subclones con-
taining hybridizing regions are also indicated. pM, IgM membrane
exons; A, synthetic EcoRI linker site.
FIG. 3. RNA blots of cytoplasmic mRNA from IR731 rat myeloma
(lanes A-C) and GCL-2.1 (lane D), a M+S+ mouse cell line, with nick-
translated C, probes. Lanes: A, p82; B, p832; C, p88; Dp82. Fragment
sizes are shown in kb.
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We have also observed two corresponding species in a mouse
A'S' cell line (GCL-2.1) (Fig. 3).
Because the 1.6-kb mRNA is the major species in IR731
myeloma cells which secrete IgD, we propose that p832 en-
codes a 85 terminus for 8 chain secretion. The p88 sequence in
the 2.7-kb mRNA may encode a 8m terminus for membrane-
bound 8 chains. We propose that these alternative 3' sequences
are spliced to the C83 domain to generate either 8, or 8m mRNA.
This arrangement is different from that of /,m and /.m mRNA,
in which the 1, terminus encoding sequence is contiguous with
the CAJ4 domain (15, 18).
A+6+ B-Cell DNA Contains Rearranged C and Germ-Line
Cc, Genes. The lymphoma lines L1OA and K46 are B-cell tumors
and express both IgM and IgD molecules on the cell surface
(19). We carried out Southern blot experiments with DNA pre-
pared from these tumor cells, using BALB/c embryo DNA as
a control. Fig. 4A shows a Southern blot of a Kpn I digest of
mouse embryo and K46 DNA with the CM cDNA clone as probe.
In embryo DNA, this C, probe hybridizes to a fragment 13
kb long. This fragment contains both the C, gene and the JH
gene cluster (27). In K46 DNA, the C, gene appears on an
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FIG. 4. (Upper) Hybridization of plO4EIL12 toKpn I digests of K46
and mouse embryo DNA. (Lower) Hybridization of the 0,3 probe to
BamHI, EcoRI, and HindHI digests of K46, mouse embryo, and
L1OA DNA. Hybridization conditions: 5X SET, 2X Denhardt's, 0.5%
NaDodSO4, 680C.
=20-kb restriction fragment, which indicates that a DNA rear-
rangement has occurred, presumably the V-J joining event (27)
(similar results were obtained with L1OA DNA). Note that a
faint band is present in K46 DNA which corresponds to the
germ-line C, gene. Both K46 and L10A are polyploid (28), and
this band could represent an unrearranged chromosome. Al-
ternatively, it could arise from DNA derived from contaminat-
ing host tissue.
The corresponding data for the Ca gene are shown in Fig. 4B
for K46, embryo, and L10A DNAs. The probe used in this ex-
periment was a 0.68-kb BamHI/Xba I restriction fragment from
p82 which contains the C.3 domain and 340 nucleotides of
pBR322. This Cs probe hybridizes to identical bands in both
embryo and lymphoma DNA restriction digests. No other hy-
bridization could be detected. Furthermore, the bands ob-
served in Fig. 4B are identical in size to those observed in
ChSpu7 and ChSp37, which demonstrates that these latter
clones contain no detectable cloning artifacts.
Analogous experiments were carried out with p88 and p832
as probes. In each case, hybridization to germ-line and lym-
phoma DNA restriction digests gave similar results (data not
shown), indicating that no rearrangement of the C, gene or its
flanking sequences occurs in ,u+5' lymphoma DNA.
We also have obtained similar results by using the tL'8' nor-
mal B-cell library. When 1.75 x 106 and 3.2 X 106 recombinant
phage were screened with the C, and C,, probes, respectively,
a total of 4 C, clones and 11 CM clones were isolated. Six of the
11 C,, clones also contained theJH locus, and 5 of these showed
rearrangements consistent with VH-D-JH joining. Restriction
map analysis of the C, and CAclones revealed that they all con-
tain only germ-line DNA within the CM gene, between C. and
the downstream EcoRI site (Fig. 1), and in the C, gene and 3'-
flanking sequence. The possibility that we simply failed to clone
or detect a rearranged C, gene cannot be ruled out; however,
these results are consistent with those described above and sug-
gest that, insofar as can be detected by gel electrophoresis, the
C; gene in A'S' B cell and lymphoma DNA is unrearranged.
Thus, we conclude that the simultaneous expression of IgM
and IgD molecules on the B lymphocyte surface does not in-
volve rearrangement of the C, gene or, by implication, a VH-
C., DNA switch recombination.
IR731 Myeloma DNA Contains a Rearranged C8 Gene and
Has Deleted the CA Gene. Using the tL cDNA clone and the
restriction fragment encoding the C83 domain as probes, we also
examined the disposition of the C and C; genes in IR731 my-
eloma DNA. DNA from Lou/M/Wsl N rat liver served as a
control (Fig. 5). Both probes cross hybridized with the rat genes
on a Southern blot of Lou/M/Wsl N liver DNA. Results ob-
tained with the C,, probe indicate that the C,, gene has been
largely deleted from the myeloma DNA (Fig. SA). The corre-
sponding experiment with the C83 probe and three restriction
endonucleases revealed that the C, gene had undergone DNA
rearrangement.
These data indicate that the C8 gene in this IgD-producing
myeloma has been rearranged, unlike that in mouse 4u+6 B
cells. Several explanations for these contrasting results should
be considered. First, IgD expression in the rat may be funda-
mentally different from that in the mouse, although we believe
that there exists no other evidence to indicate that this might
be the case. Second, these observations could be an artifact of
the myeloma condition. For example, the significance of "abor-
tive" rearrangements observed in mouse plasmacytomas (29) is
not understood. Finally, these results could conceivably be at-
tributed to a minor substrain difference between Lou/M/Wsl
N, the tumor host, and Lou/C/Wsl (16), in which IR731 ap-
peared.
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FIG. 5. (Left) Hybridization of plO4Ep.12 to Lou/M/Wsl N liver
and ER731 DNA digested withBamHI, Bgl IL andXba I. (Right) South-
ern blot of Lou/M/Wsl N liver and IR731 DNA restriction enzyme
digests with the C,3 probe. (C) Hybridization of theJH probe toHindillI
and BamHI digests of Lou/MN liver and IR731 DNA. Hybridization
conditions were: 5X SET, 2X Denhardt's, 0.5% NaDodSO4, 62'C. Frag-
ment sizes are in kb.
To address the latter two questions, we carried out Southern
blot experiments using p88, p832, a y3 cDNA clone from my-
eloma J606, and a plasmid subelone containing the mouse JH
gene cluster and its 3' flanking sequence. The p88 and p832
clones gave similar results with Lou/M/Wsl N liver and Lou/
C/Wsl myeloma (IR731) DNA: in each case, both hybridized
to a single 5.7-kb EcoRI fragment. The y3 cDNA probe also
hybridized to 9.2-, 14-, and 16-kb EcoRI fragments in both DNA
samples. Thus, the C, genes and the counterparts of p832 and
p88 in the rat genome display no polymorphism in the two sub-
strains. These results suggest that DNA rearrangement rather
than restriction enzyme site polymorphism is responsible for
the observed difference in hybridization of the C83 probe to Lou/
M/Wsl N liver and IR731 DNA and that this rearrangement has
occurred on the 5' side of p832 and p88.
Although the C, gene had been deleted from IR731 DNA,
results obtained with the JH probe (Fig. 5C) indicate that the
JH genes and 3'-flanking sequence are still present and have
been rearranged, as would be expected for a V-D-JH joining
event. This observation suggests that a VH-Ca switch recom-
bination has indeed occurred in IR731 DNA.
Two Alternative Mechanisms for the Expression of IgD.
Based on the results described above, we propose the existence
of two different molecular mechanisms for the expression of the
C5 gene. First, in gu 8+ B cells, these results suggest regulation
at the level of RNA processing, probably involving multiple
sites for splicing and poly(A) addition. This type of control has
been observed in late adenovirus mRNA processing (30-32) and
has been implicated in the synthesis of membrane-bound and
secreted IgM (/um and us) mRNA from a single transcript (15).
This mechanism presupposes the existence of a poly(A) addition
site 3' to the C., gene. Extension of a transcript beyond the
poly(A) addition sites of us and gim mRNA would then generate
the precursor of 8 mRNA. Wall et al. (33) pointed out that, ac-
cording to this model, the preferential utilization of the ps
poly(A) site which would accompany the initiation of /is syn-
thesis would halt production of membrane-bound IgM and IgD
molecules. Results have been obtained which agree with this
prediction (34-36). The C, gene thus could be another example
in eukaryotes in which developmentally regulated RNA splicing
generates alternative protein forms. We believe that this control
mechanism will be a general one in eukaryotic gene expression.
The second mechanism, apparently used by the rat IgD my-
eloma IR731, involves deletion of CA and rearrangement of C,,
presumably via a VH-CS switch recombination. We infer the
presence of one or more switch sites (37), probably in the region
between C8 and the IgM M exons. At present, the mechanism
of this particular switching event remains unknown. We predict
that, generally, IgD-secreting cells also will exhibit rearrange-
ment of the C, gene. A schematic representation of these mech-
anisms is given in Fig. 6.
CH Gene Linkage Family andCH Gene Expression. The data
in this paper and those from other laboratories (38-40), allow
construction of a linkage map of the immunoglobulin heavy
chain gene family (Fig. 6, top line). Because the separation be-
tween the CMA and C., genes is substantially smaller than that for
other CH genes, we believe that the CM-C, system is likely to
be the only pair of CH genes that uses an RNA processing mech-
anism as proposed above for their expression. Expression of
other heavy chain genes (Cat Cal CQ) most likely will occur only
by the CH switching mechanism involving DNA rearrangement.
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Note. After this manuscript was submitted for review, two
articles (41, 42) describing detailed structural studies of the
mouse C., gene appeared. Our data on the structure of the Can
gene largely agree with the data presented in them.
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